ATE366118T1 - Verwendung von immuntherapeutischem wirkstoff auf peptidbasis - Google Patents

Verwendung von immuntherapeutischem wirkstoff auf peptidbasis

Info

Publication number
ATE366118T1
ATE366118T1 AT97912439T AT97912439T ATE366118T1 AT E366118 T1 ATE366118 T1 AT E366118T1 AT 97912439 T AT97912439 T AT 97912439T AT 97912439 T AT97912439 T AT 97912439T AT E366118 T1 ATE366118 T1 AT E366118T1
Authority
AT
Austria
Prior art keywords
peptide
based immunotherapeutic
immunotherapeutic agent
patient
immunotherapy
Prior art date
Application number
AT97912439T
Other languages
English (en)
Inventor
Toshio Sone
Akinori Kume
Kazuo Dairiki
Kohsuke Kino
Original Assignee
Meiji Dairies Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Dairies Corp filed Critical Meiji Dairies Corp
Application granted granted Critical
Publication of ATE366118T1 publication Critical patent/ATE366118T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56977—HLA or MHC typing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Botany (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
AT97912439T 1996-11-13 1997-11-12 Verwendung von immuntherapeutischem wirkstoff auf peptidbasis ATE366118T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP30205396 1996-11-13

Publications (1)

Publication Number Publication Date
ATE366118T1 true ATE366118T1 (de) 2007-07-15

Family

ID=17904350

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97912439T ATE366118T1 (de) 1996-11-13 1997-11-12 Verwendung von immuntherapeutischem wirkstoff auf peptidbasis

Country Status (10)

Country Link
US (1) US7025964B1 (de)
EP (1) EP0958834B1 (de)
JP (1) JP4218987B2 (de)
KR (1) KR100540417B1 (de)
CN (1) CN100364611C (de)
AT (1) ATE366118T1 (de)
AU (1) AU736977C (de)
CA (1) CA2270877C (de)
DE (1) DE69737891T2 (de)
WO (1) WO1998020902A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040072262A1 (en) 2002-10-11 2004-04-15 Montero-Julian Felix A. Methods and systems for detecting MHC class I binding peptides
WO2004047793A1 (en) 2002-11-26 2004-06-10 Alk-Abelló A/S Pharmaceutical allergen product
EP2226332A1 (de) 2004-06-17 2010-09-08 Beckman Coulter, Inc. Mycobacterium-tuberculosis-Epitope und Verfahren zu deren Verwendung
JP3987563B2 (ja) * 2006-10-23 2007-10-10 第一三共株式会社 ペプチド及びその用途
JP3987562B2 (ja) * 2006-10-23 2007-10-10 第一三共株式会社 ペプチド及びその用途
JP5875246B2 (ja) * 2010-12-10 2016-03-02 日東電工株式会社 シート状製剤及びシート状製剤の製造方法
EP2812028A4 (de) 2012-02-07 2016-01-06 Jolla Inst Allergy Immunolog Epitope von allergenen proteinen sowie verfahren und verwendung zur immunreaktionsmodulation
GB201601872D0 (en) * 2016-02-02 2016-03-16 Circassia Ltd Japanese cedar and japanese cypress peptides for preventing or treating allergy
CN114450302A (zh) * 2019-07-30 2022-05-06 大学健康网络 Mhc ii类分子及其使用方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL92629A0 (en) 1989-12-10 1990-08-31 Yeda Res & Dev Direct binding of t-cell epitopes to mhc gene products on intact living antigen presenting cells and the use thereof for identifying epitopes causing autoimmune diseases and pharmaceutical compositions for treating such diseases
WO1993001213A1 (en) 1991-07-12 1993-01-21 Immulogic Pharmaceutical Corporation Allergenic proteins and peptides from japanese cedar pollen
WO1994001560A1 (en) 1991-07-12 1994-01-20 Immulogic Pharmaceutical Corporation Allergenic proteins and peptides from japanese cedar pollen
DE69233772D1 (de) * 1991-10-16 2009-11-12 Merck Patent Gmbh T-zell epitopen von den wichtigsten allergene von dermatophagoides (hausmilbe)
EP0659214A1 (de) * 1992-09-01 1995-06-28 Immulogic Pharmaceutical Corporation Allergene Proteine und Peptide aus Pollen vom japanischen Zeder.
DE4238416A1 (de) 1992-11-13 1994-05-19 Max Planck Gesellschaft Bestimmung von Peptidmotiven auf MHC-Molekülen
US5939283A (en) 1992-12-31 1999-08-17 Immulogic Pharmaceutical Corporation Allergenic proteins and peptides from dog dander and uses therefor
JP3474898B2 (ja) 1993-10-20 2003-12-08 明治乳業株式会社 スギ花粉アレルゲンのｔ細胞エピトープペプチド及びそのアナログペプチド
JP3649460B2 (ja) 1993-11-05 2005-05-18 明治乳業株式会社 スギ花粉アレルゲンＣｒｙ ｊ ＩＩエピトープ
JP4179422B2 (ja) * 1994-04-08 2008-11-12 メルク パテント ゲーエムベーハー スギ花粉アレルギーを治療するための医薬組成物
JP3588165B2 (ja) * 1995-07-14 2004-11-10 株式会社林原生物化学研究所 ペプチドとその用途
TW438807B (en) 1994-09-10 2001-06-07 Hayashibara Biochem Lab Novel peptides containing T-cell epitope(s) of cedar pollen allergens, the processes therefor and the pharmaceutical uses thereof
JP3734855B2 (ja) 1995-04-07 2006-01-11 株式会社林原生物化学研究所 ペプチド及びその用途
WO1997032600A1 (fr) 1996-03-10 1997-09-12 Meiji Milk Products Co., Ltd. Agent immunotherapeutique a base peptidique pour le traitement des allergies

Also Published As

Publication number Publication date
WO1998020902A1 (en) 1998-05-22
US7025964B1 (en) 2006-04-11
CA2270877A1 (en) 1998-05-22
CN100364611C (zh) 2008-01-30
EP0958834A1 (de) 1999-11-24
CA2270877C (en) 2011-08-23
DE69737891T2 (de) 2008-03-13
KR20000053216A (ko) 2000-08-25
AU736977B2 (en) 2001-08-09
JP4218987B2 (ja) 2009-02-04
EP0958834A4 (de) 2003-04-09
DE69737891D1 (de) 2007-08-16
KR100540417B1 (ko) 2006-01-10
EP0958834B1 (de) 2007-07-04
AU736977C (en) 2007-10-18
CN1244804A (zh) 2000-02-16
AU4964997A (en) 1998-06-03

Similar Documents

Publication Publication Date Title
DK0666760T4 (da) Vaccine som omfatter en del af den konstante region af IgE til behandling af IgE-medierede allergiske reaktioner
ATE255902T1 (de) Ein anti-idiotypischer antikörper und seine verwendung in der diagnose und therapie von hiv- verwandten krankheiten
DE69310677D1 (de) Behandlung von Brennstoffgasen, insbesondere für Brennstoffzellen und Vorrichtung dafür
EP0796273A4 (de) Varianten von antigenen des menschlichen papillomvirus
NO992196L (no) Notch
DE3751470D1 (de) Pentigetide zur Behandlung von nicht-IgE-vermittelten entzündlichen Erkrankungen.
FI960309L (fi) Neisseria meningitidis, B-ryhmän ulkomembraanin poriiniproteiinien korkean tason ilmentäminen, puhdistaminen ja uudelleenlaskostaminen
SE8501050D0 (sv) Biologically active fragments of human antihemophilic factor and method for preparation thereof
KR900009079A (ko) 비스(3,5-디-tert-부틸-4-히드록시페닐티오)메탄 함유 콜레스테롤 저하제겸 아테롬성 동맥 경화증 치료제
ATE366118T1 (de) Verwendung von immuntherapeutischem wirkstoff auf peptidbasis
DE3578611D1 (de) Instrumente zur behandlung von verformten naegeln bei menschlichen patienten.
NO904023L (no) Blanding som induserer binding.
ATE495240T1 (de) Ligand des zelleintritt-vermittelnden proteins von herpes simplex virus und methoden zu dessen verwendung
DE69524663D1 (de) Verwendung von Extracten aus filamentösen Bakterien als kosmetische Mittel gegen Hautaltern
DE68910175D1 (de) Adsorbermodul sowie Adsorberapparat zur Behandlung von Vollblut.
DE69638024D1 (de) Melanoma antigene p15 und deren anwendung in diagnostischen und therapeutischen verfahren
DK0614975T3 (da) Glycoproteinhormonreceptormolekyler
ATE105938T1 (de) Monoklonale antikörper gegen spezifische antigene regionen des humanen immundefizienzvirus und methoden zur verwendung.
ATE206458T1 (de) T-zellen stimulierendes protein von pestivirus
TR199800575T1 (en) Kemokin �-8'in k�sa formlar�.
ATE66591T1 (de) Pantethinkomponente zum dauerwellen von haar.
ATE149344T1 (de) Verwendung von hydroxynaphthalinen in färbemitteln
ATE214923T1 (de) Verwendung von (r)-verapamil als medizin zur behandlung von angina
DE68904322D1 (de) Einrichtung zur behandlung von gasen.
DE59003265D1 (de) Verwendung von nor-verapamil und nor-gallopamil als antiarteriosklerotica.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties